Filter for truly exceptional businesses with our ROIC analysis. Return on invested capital and economic value added calculations to find companies generating superior returns on every dollar deployed. Quality metrics that separate the best from the rest.
AbbVie Inc. (NYSE: ABBV) released its Q1 2026 quarterly results on May 2, 2026, reporting in-line revenue of $15 billion but a 69% miss on statutory earnings per share (EPS) at $0.39. Shares rose 4.0% post-release to $207, as investors and analysts viewed the profitability shortfall as transitory. C
AbbVie Inc. (ABBV) - Q1 2026 Earnings Miss Fails to Shift Analyst Consensus Outlook - Quarterly Earnings Report
ABBV - Stock Analysis
3496 Comments
1802 Likes
1
Braelyne
Trusted Reader
2 hours ago
Regret not seeing this sooner.
👍 86
Reply
2
Leighton
Community Member
5 hours ago
Too bad I wasn’t paying attention earlier.
👍 258
Reply
3
Markai
Daily Reader
1 day ago
Markets appear cautious, with mixed volume across major sectors.
👍 104
Reply
4
Nabi
Community Member
1 day ago
This deserves endless applause. 👏
👍 264
Reply
5
Huberta
Experienced Member
2 days ago
I read this and now I’m thinking too much.
👍 244
Reply
© 2026 Market Analysis. All data is for informational purposes only.